top of page
All Posts
Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
Alesta Therapeutics Secures €65 Million in Series A Funding to Develop Oral Small Molecules for Rare Diseases
Karin Folman
Jan 8, 20253 min read
bottom of page